Navigation Links
gloStream Announces Release of Microsoft-Based, Meaningful Use Certified gloEMR 6.0
Date:1/12/2011

TROY, Mich., Jan. 12, 2011 /PRNewswire/ -- gloStream, maker of gloEMR and gloPM – the only electronic medical record ("EMR") and practice management ("PM") software with Microsoft Office built right in – today announced the release of gloEMR 6.0., the sixth major upgrade to the gloEMR product line. Like its predecessor versions, gloEMR 6.0 leverages a variety of Microsoft technology such as the .NET platform, SQL Server and Microsoft Office so users have access to the most powerful and widely used technology available anywhere.

gloEMR offers a host of new features doctors can use to improve efficiency, productivity, and compliance with meaningful use criteria, which they must prove to collect Stimulus incentive funding.  This includes meaningful use and clinical quality measure dashboards that allow practice staff to track their compliance against all established criteria, in real time. In addition, the dashboards provide a mechanism for staff to pull data and report meaningful user status to the government, a key feature for all physicians seeking to acquire Stimulus funding.

"The tens of thousands of hours we've spent developing and testing gloEMR 6.0 have resulted in a product that is feature-rich, flexible and customizable to the specific needs of each practice we serve," said Piyush Khanna, gloStream's Chief Information Officer.  "gloEMR 6.0 provides doctors with important tools to ensure meaningful use compliance while also maximizing productivity via dashboards, personal health record integration, reporting and much, much more."

Additional, important key features within gloEMR include:

  • A fully customizable main dashboard homepage area.
  • HL7-standard Continuity of Care Documents ("CCDs") that can be sent and synched with other EMRs as well as personal health record applications such as Microsoft's HealthVault.
  • gloLabs Clearinghouse which provides access to more than 150 Labs.
  • Microsoft Reporting Services integration which offers the ability to create customizable reports based on clinical and financial information.
  • E&M coding and support for SNOMED.

gloEMR 6.0 was one of the very first EMRs to be ONC-ATCB 2011/2012 certified through the Certification Commission for Health Information Technology ("CCHIT").  As such, doctors using gloEMR 6.0 can be confident it contains all of the functionality needed for them to demonstrate meaningful use and collect their Stimulus payments.

About gloStream

gloStream provides physicians with certified, voice-enabled electronic medical record and practice management solutions delivered and supported through a nationwide community of local technology Partners.  gloStream products are secure, easy-to-use applications and the only solutions on the market with Microsoft Office built right in.  gloStream Partners leverage gloDNA ("gloStream Detailed Needs Analysis"), an innovative process that has given gloStream a 100 percent implementation success rate.  Every practice that has installed a gloStream application using gloDNA continues using it successfully today. For more information, visit glostream.com or call 877-456-3671.

gloEMR 6.0 from gloStream (CC-1112-501340-1), a complete EHR, is ONC-ATCB 2011/2012 compliant and has been certified by the Certification Commission for Health Information Technology (CCHIT®), an ONC-ATCB, in accordance with the applicable certification criteria for eligible providers adopted by the Secretary of Health and Human Services. gloEMR was certified on Sept 30, 2010, and has been certified for the following clinical quality measures: NQF 0421, NQF 0013, NQF 0028, NQF 0041, NQF 0024, NQF 0038, NQF 004, NQF, 0012, NQF 0032. This certification does not represent an endorsement by the U.S. Department of Health and Human Services or guarantee the receipt of incentive payments.


'/>"/>
SOURCE gloStream
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. ADVENTRX Announces Fast Track Designation Granted By the FDA For CoFactor For the Treatment of Metastatic Colorectal Cancer
5. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
6. Phosphagenics Announces Positive Phase 1b Transdermal Insulin Clinical Trial Results
7. Xenomics Announces Implementation of its First Diagnostic Test for Acute Myeloid Leukemia Into Clinical Practice
8. Emisphere Technologies, Inc. Announces 2007 Second Quarter Financial Results
9. Amicus Therapeutics Announces Second Quarter 2007 Financial Results
10. Genta Incorporated Announces Second Quarter 2007 Financial Results and Corporate Highlights
11. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/5/2016)... , Dec. 5, 2016  BD (Becton, Dickinson ... global medical technology company, will demonstrate an enhanced technology ... management technologies, including the company,s leading Pyxis™ and Alaris™ ... Pharmacists (ASHP) 2016 Midyear Meeting being held in ... While national data show that approximately 68 ...
(Date:12/5/2016)... Research and Markets has announced the addition of the "Global ... and Demand Forecast to 2022" report to their offering. ... , , ... market is expected to grow at a CAGR of 4.5% during ... witnessing high growth, due to growing female geriatric population and increasing ...
(Date:12/5/2016)... England , December 5, 2016 ... Transitions to Deputy Chairman   ... on selectively targeting deubiquitylating enzymes (DUBs) to treat cancer, neurodegenerative ... has been appointed as non-executive Chairman, effective January 1 st ... of Mission Therapeutics as a non-executive Director in July 2015. ...
Breaking Medicine Technology:
(Date:12/5/2016)... ... December 05, 2016 , ... ... and relationship-marketing firm, announced today that nominations will be accepted from December ... (ISE®) Central Awards. , Awards include the Information Security Executive® of the ...
(Date:12/5/2016)... ... December 05, 2016 , ... ... Meeting through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on ... in 26 people will be diagnosed with epilepsy within their lifetime. With such ...
(Date:12/5/2016)... , ... December 05, 2016 ... ... interoperability, today announced that the company will provide alerting technology to Central ... been recently awarded $1.7 million in federal funds as the sole sub-recipient ...
(Date:12/5/2016)... ... December 05, 2016 , ... Dr. Barry M. Weintraub, one ... Surgery, who recently participated in the 36th Annual Cutting Edge Aesthetic Symposium at the ... techniques for getting that perfect, yet natural-looking, nose. Dr. Weintraub, who is world-renowned for ...
(Date:12/5/2016)... , ... December 05, 2016 , ... ... Officer for the Florida Hospital West Florida Region. McGuinness brings experience in executive ... and engaging staff, physicians and leaders. , In her new role, that officially ...
Breaking Medicine News(10 mins):